MYC and familial pancreatic carcinoma: The probes in the panel (1q21, 7p12, 8q24, and 9p21) were first evaluated on 30 selected samples of tumor tissue (CCA and pancreatic cancer) where gain of 8q24 (MYC) was observed in 44% of the tumor cells analyzed.